GLP-1 medications are now widely used for diabetes and weight management, and their use is expanding rapidly, Haroun Haque, MS, a third-year medical student at SUNY Downstate College of Medicine and lead investigator of this study, told Medical News Today
The phase 2 type 2 diabetes trial also reported dose-dependent bodyweight decreases at 36 weeks, including 16.94% in the 12 mg group versus 3.00% with placebo [5]
doi: 10.1007/s11064-020-03030-1
We have not seen health insurance cover treatment for acne or acne scars, and cosmetic sun damage doesnt meet their requirements for medical necessity
This is where meaningful weight loss accelerates for most patients
Timeline: Some peptides (like BPC-157 for injuries) may show effects within weeks, while others (like GHK-Cu for collagen synthesis) work over months